BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for BioLineRx Ltd. (BLRX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for BioLineRx Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2020-11-03
4:39 pm
Sale		 2020-10-30 13G BioLineRx Ltd.
BLRX		 BIOTECHNOLOGY VALUE FUND L P 148,671
1.900%		 -632,391decrease
(-80.97%)		 Filing
2020-06-01
5:37 pm
Sale		 2020-05-28 13G BioLineRx Ltd.
BLRX		 BIOTECHNOLOGY VALUE FUND L P 781,062
11.800%		 -17,498decrease
(-2.19%)		 Filing